Table 4.
Prescription of ceftriaxone, spectinomycin, and/or azithromycin for gonorrhoea cases registered in Flemish general practice 2009–2013 (n = 91), Intego database; in brackets (): number of cases with chlamydia coinfection; in double brackets (()): number of cases with genital trichomonas coinfection.
| 2009 | 2009 (%) | 2010 | 2010 (%) | 2011 | 2011 (%) | 2012 | 2012 (%) | 2013 | 2013 (%) | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total number of gonorrhoea cases recorded | 15 (1) | 22 (2) | 17 (4) | 21 (3) | 16 ((1)) | 91 (10) ((1)) | |||||
|
| |||||||||||
| No antibiotic recorded | 1 | 7% | 5 | 23% | 0 | 0% | 4 | 19% | 3 | 19% | 13 |
|
| |||||||||||
| Prescribed antibiotic(s) include | |||||||||||
| Ceftriaxone | 0 | 0% | 3 | 14% | 6 (2) | 35% | 6 (2) | 29% | 9 | 56% | 24 (4) |
| Spectinomycin | 2 (1) | 13% | 1 | 5% | 2 (1) | 12% | 4 | 19% | 0 | 0% | 9 (2) |
| Ceftriaxone and spectinomycin | 0 | 0% | 0 | 0% | 1 (1) | 6% | 1 | 5% | 0 | 0% | 2 (1) |
| Ceftriaxone and/or spectinomycin | 2 (1) | 13% | 4 | 18% | 7 (2) | 41% | 9 (2) | 43% | 9 | 56% | 31 (5) |
| Azithromycin | 2 | 13% | 2 | 9% | 6 (3) | 35% | 7 (3) | 33% | 10 ((1)) | 63% | 27 (6) ((1)) |
| Ceftriaxone and/or spectinomycin together with azithromycin | 0 | 0% | 1 | 5% | 3 (2) | 18% | 4 (2) | 19% | 7 | 44% | 15 (4) |